Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    April 2019
  1. HENLEY D, Raghavan N, Sperling R, Aisen P, et al
    Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.
    N Engl J Med. 2019;380:1483-1485.
    PubMed     Text format    


  2. EGAN MF, Kost J, Voss T, Mukai Y, et al
    Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
    N Engl J Med. 2019;380:1408-1420.
    PubMed     Text format    


  3. KNOPMAN DS
    Lowering of Amyloid-Beta by beta-Secretase Inhibitors - Some Informative Failures.
    N Engl J Med. 2019;380:1476-1478.
    PubMed     Text format    


    May 2018
  4. EGAN MF, Kost J, Tariot PN, Aisen PS, et al
    Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
    N Engl J Med. 2018;378:1691-1703.
    PubMed     Text format     Abstract available


    March 2018
  5. DEVI G
    Alzheimer's Disease in Physicians - Assessing Professional Competence and Tempering Stigma.
    N Engl J Med. 2018;378:1073-1075.
    PubMed     Text format    


    January 2018
  6. MURPHY MP
    Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease.
    N Engl J Med. 2018;378:391-392.
    PubMed     Text format    


  7. HONIG LS, Vellas B, Woodward M, Boada M, et al
    Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
    N Engl J Med. 2018;378:321-330.
    PubMed     Text format     Abstract available


    May 2017
  8. SACKS CA, Avorn J, Kesselheim AS
    The Failure of Solanezumab - How the FDA Saved Taxpayers Billions.
    N Engl J Med. 2017;376:1706-1708.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: